Chengdu Kanghua Biological Products Co., Ltd. (SZSE: 300841)
Health Care · Biotechnology · CN
CN¥56.50
+15.68% today · -33.6% 1Y
Chengdu Kanghua Biological Products Co., Ltd. (SZSE: 300841) operates in the Biotechnology industry within the Health Care sector. The company is valued at $1.09B and employs 550 people.
Over the last twelve months the share price has lost 33.6%, trading between 42.31 and 86.86.
Tweenvest scores Chengdu Kanghua Biological Products Co., Ltd. across four factors: quality 72/100, value 51/100, growth 11/100, dividend 27/100. Its strongest factor is quality.
300841 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $1.09B
- Revenue (TTM)
- $179.52M
- P/E
- 29.78
- EPS
- 1.90
- Dividend yield
- 0.88%
- Beta (5Y)
- 0.39
- 52-week high
- CN¥86.86
- 52-week low
- CN¥42.31
- Avg volume (3M)
- —
- Shares outstanding
- 129.95M
- Employees
- 550
- Next earnings
- —
About Chengdu Kanghua Biological Products Co., Ltd.
Chengdu Kanghua Biological Products Co., Ltd. engages in the research, development, production, sale, and technical service of biological products in China. It offers group ACYW135 meningococcal polysaccharide vaccines; and freeze-dried human diploid cell rabies vaccines. The company also develops seasonal influenza vaccines. In addition, it exports its products. Chengdu Kanghua Biological Products Co., Ltd. was founded in 2004 and is based in Chengdu, China.
- Founded
- 2004
- Listed since
- Jun 16, 2020
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.